Δ12-Prostaglandin J2 is widely studied for its role in cellular signaling and inflammation regulation. It has been shown to induce apoptosis in various cancer cells, making it a potential candidate for cancer therapy research. Additionally, it modulates the activity of nuclear receptors and transcription factors, such as PPARγ, which is involved in metabolic and inflammatory processes. This compound is also explored for its neuroprotective effects, particularly in models of neurodegenerative diseases, where it helps reduce oxidative stress and inflammation. Its ability to influence immune responses further highlights its potential in treating autoimmune and inflammatory conditions.